Despite often being classified as a SARM, cardarine (GW 501516) is technically a PPAR-delta agonist (peroxisome proliferator-activated receptors). It is commonly marketed as a SARM, analogous to how a tomato, botanically a fruit, is sold as a vegetable. Initially discovered through collaborations between GSK and Ligand Pharma in the early 1990s, cardarine entered phase 1 trials in 2000 for addressing lipid strain but was discontinued in 2008. Today, it serves as a research compound and is utilized by athletes for performance enhancement and fat burning.
 
Medical Uses: Primarily developed to address obesity, diabetes, lipid strain, and heart health issues, cardarine has proven beneficial for lipid strain and substantial improvement in cholesterol levels.